About Sudeep Pharma
Sudeep Pharma is a company based in Vadodara (India) founded in 1989. Sudeep Pharma has raised $18.75 million across 1 funding round from investors including Nuvama, WhiteOak Capital Management and Dalmia Family Office Trust. The company has 377 employees as of April 03, 2024. Sudeep Pharma offers products and services including Calcium Phosphate, Calcium Carbonate, Iron Salts, and Magnesium Salts. Sudeep Pharma operates in a competitive market with competitors including Colorcon, Pfanstiehl, SPI Pharma, Scope Ingredients and Meggle Pharma, among others.
- Headquarter Vadodara, India
- Employees 377 as on 03 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sudeep Pharma Limited
-
Annual Revenue
$58.17 M (USD)9.4as on Mar 31, 2025
-
Net Profit
$16.27 M (USD)4.14as on Mar 31, 2025
-
EBITDA
$22.24 M (USD)5.55as on Mar 31, 2025
-
Total Equity Funding
$18.75 M (USD)
in 1 rounds
-
Latest Funding Round
$18.75 M (USD), Series B
May 15, 2025
-
Investors
Nuvama
& 4 more
-
Employee Count
377
as on Apr 03, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Sudeep Pharma
Sudeep Pharma is a publicly listed company on the NSE with ticker symbol SUDEEPPHRM in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Sudeep Pharma
Sudeep Pharma offers a comprehensive portfolio of products and services, including Calcium Phosphate, Calcium Carbonate, Iron Salts, and Magnesium Salts.
Serves as a binder in pharmaceutical and food formulations.
Provides calcium for nutrition and pharmaceutical applications.
Used in fortified foods and supplements for mineral delivery.
Supports formulations in pharmaceuticals and dietary products.
Funding Insights of Sudeep Pharma
Sudeep Pharma has successfully raised a total of $18.75M through 1 strategic funding round. The most recent funding activity was a Series B round of $18.75 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sudeep Pharma
Sudeep Pharma has secured backing from 5 investors, including institutional and angel investors. Prominent investors backing the company include Nuvama, WhiteOak Capital Management and Dalmia Family Office Trust.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management and advisory services are provided in India.
|
Locked | Locked | Locked | |
|
An integrated wealth management platform is operated by Nuvama.
|
Locked | Locked | Locked | |
|
MA
Mukul Agrawal |
-
|
Locked | Locked | Locked |
Investor details for Sudeep Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sudeep Pharma
Investment portfolio details for Sudeep Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sudeep Pharma
Detailed financials for Sudeep Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sudeep Pharma Comparisons
Peer comparison for Sudeep Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sudeep Pharma
Sudeep Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Colorcon, Pfanstiehl, SPI Pharma, Scope Ingredients and Meggle Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of specialty excipients and corporate-backed venture capital fund focused on healthcare startups
|
|
| Locked | Locked | Locked |
APIs, injectable excipients, and bioprocessing solutions are manufactured.
|
|
| Locked | Locked | Locked |
Excipient products and formulations are manufactured for pharmaceutical uses.
|
|
| Locked | Locked | Locked |
Formulations, warehousing, and logistics services for pharmaceuticals are provided.
|
|
| Locked | Locked | Locked |
Develops and manufactures pharmaceutical excipients for the industry.
|
|
| Locked | Locked | Locked |
Supplies excipients, coatings, and technical services for health sciences worldwide.
|
Detailed competitors of Sudeep Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sudeep Pharma
Complete news archive for Sudeep Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudeep Pharma
Sudeep Pharma was founded in 1989 and raised its 1st funding round 36 years after it was founded.
Sudeep Pharma is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
Sudeep Pharma is a funded company, having raised a total of $18.75M across 1 funding round to date.
As of Apr 03, 2024, the latest employee count at Sudeep Pharma is 377.
Annual revenue of Sudeep Pharma is $58.17M as on Mar 31, 2025.
Sudeep Pharma was founded in 1989 in Vadodara, India, where operations center on producing pharmaceutical excipients and ingredient solutions. Products are supplied to sectors including pharmaceuticals and beverages, with a portfolio that addresses specific industry needs. Quality standards are maintained through established processes, and solutions are developed to support customer requirements in these fields. The companys domain is sudeeppharma.com.
Sudeep Pharma's top competitors include Colorcon, DFE Pharma and Crest Cellulose.
Sudeep Pharma offers Calcium Phosphate, Calcium Carbonate, Iron Salts, and Magnesium Salts.
Yes, Sudeep Pharma is publicly traded on NSE under the ticker symbol SUDEEPPHRM.
Sudeep Pharma has 5 investors. Key investors include Nuvama, WhiteOak Capital Management, Dalmia Family Office Trust, Mukul Agrawal, and Sanshi Fund.
The ticker symbol of Sudeep Pharma is SUDEEPPHRM on NSE.